• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CHK2激酶——一位忙碌的信使。

CHK2 kinase--a busy messenger.

作者信息

Bartek J, Falck J, Lukas J

机构信息

Danish Cancer Society, Institute of Cancer Biology, Strandboulevarden 49, DK-2100 Copenhagen Ø, Denmark.

出版信息

Nat Rev Mol Cell Biol. 2001 Dec;2(12):877-86. doi: 10.1038/35103059.

DOI:10.1038/35103059
PMID:11733767
Abstract

Checkpoint kinase 2 (Chk2) is emerging as a key mediator of diverse cellular responses to genotoxic stress, guarding the integrity of the genome throughout eukaryotic evolution. Recent studies show the fundamental role of Chk2 in the network of genome-surveillance pathways that coordinate cell-cycle progression with DNA repair and cell survival or death. Defects in Chk2 contribute to the development of both hereditary and sporadic human cancers, and earmark this kinase as a candidate tumour suppressor and an attractive target for drug discovery.

摘要

检验点激酶2(Chk2)正逐渐成为细胞对基因毒性应激多种反应的关键调节因子,在整个真核生物进化过程中维护基因组的完整性。最近的研究表明,Chk2在基因组监测途径网络中发挥着重要作用,该网络可协调细胞周期进程与DNA修复以及细胞存活或死亡。Chk2的缺陷会导致遗传性和散发性人类癌症的发生,这使该激酶成为候选肿瘤抑制因子以及药物研发的一个有吸引力的靶点。

相似文献

1
CHK2 kinase--a busy messenger.CHK2激酶——一位忙碌的信使。
Nat Rev Mol Cell Biol. 2001 Dec;2(12):877-86. doi: 10.1038/35103059.
2
Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.Chk2-p53肿瘤抑制通路中伴随性缺陷与替代性缺陷的功能影响
Oncogene. 2001 Sep 6;20(39):5503-10. doi: 10.1038/sj.onc.1204811.
3
Chk1 and Chk2 kinases in checkpoint control and cancer.细胞周期检验点控制及癌症中的Chk1和Chk2激酶
Cancer Cell. 2003 May;3(5):421-9. doi: 10.1016/s1535-6108(03)00110-7.
4
Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer.
Oncogene. 2004 Nov 4;23(52):8545-51. doi: 10.1038/sj.onc.1207878.
5
Polo-like kinases and Chk2 at the interface of DNA damage checkpoint pathways and mitotic regulation.Polo样激酶与Chk2处于DNA损伤检查点通路和有丝分裂调控的交汇点。
IUBMB Life. 2004 Aug;56(8):449-56. doi: 10.1080/15216540400010826.
6
The Chk2 protein kinase.Chk2蛋白激酶。
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1039-47. doi: 10.1016/j.dnarep.2004.03.033.
7
Alterations of Chk1 and Chk2 expression in colon cancer.
Int J Colorectal Dis. 2008 Dec;23(12):1243-9. doi: 10.1007/s00384-008-0551-8. Epub 2008 Aug 5.
8
[Genes and cancer. CHK2 (CDS1, Rad53): tumor suppressor gene].
Bull Cancer. 2003 Jul;90(7):581-2.
9
Tumor suppressor CHK2: regulator of DNA damage response and mediator of chromosomal stability.肿瘤抑制因子 CHK2:DNA 损伤反应的调节因子和染色体稳定性的介导者。
Clin Cancer Res. 2011 Feb 1;17(3):401-5. doi: 10.1158/1078-0432.CCR-10-1215. Epub 2010 Nov 18.
10
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.DNA损伤反应作为人类早期肿瘤发生过程中潜在的抗癌屏障。
Nature. 2005 Apr 14;434(7035):864-70. doi: 10.1038/nature03482.

引用本文的文献

1
Oncogenic p53 induces mitotic errors in lung cancer cells by recopying DNA replication forks conferring targetable proliferation advantage.致癌性p53通过复制赋予可靶向增殖优势的DNA复制叉,在肺癌细胞中诱导有丝分裂错误。
Res Sq. 2025 Aug 13:rs.3.rs-7303237. doi: 10.21203/rs.3.rs-7303237/v1.
2
DNA Damage Repair Pathway Alterations and Immune Landscape Differences in Pediatric/Adolescent, Young Adult (AYA) and Adult Sarcomas.儿童/青少年、青年成人(AYA)及成人肉瘤中的DNA损伤修复途径改变与免疫格局差异
Cancers (Basel). 2025 Jun 12;17(12):1962. doi: 10.3390/cancers17121962.
3
Moderate-Low Risk Breast Cancer Gene Expression in a Romanian Population.
罗马尼亚人群中低-中度风险乳腺癌的基因表达
Int J Mol Sci. 2025 May 31;26(11):5313. doi: 10.3390/ijms26115313.
4
ATM is associated with the prognosis of colorectal cancer: a systematic review.共济失调毛细血管扩张症突变基因(ATM)与结直肠癌的预后相关:一项系统综述
Front Oncol. 2025 Mar 12;15:1470939. doi: 10.3389/fonc.2025.1470939. eCollection 2025.
5
ROS-ATM-CHK2 axis stabilizes HIF-1α and promotes tumor angiogenesis in hypoxic microenvironment.ROS-ATM-CHK2轴在缺氧微环境中稳定缺氧诱导因子-1α并促进肿瘤血管生成。
Oncogene. 2025 Jun;44(21):1609-1619. doi: 10.1038/s41388-025-03336-w. Epub 2025 Mar 8.
6
Guarding against digestive-system cancers: Unveiling the role of Chk2 as a potential therapeutic target.预防消化系统癌症:揭示Chk2作为潜在治疗靶点的作用。
Genes Dis. 2023 Dec 7;12(1):101191. doi: 10.1016/j.gendis.2023.101191. eCollection 2025 Jan.
7
Protein-truncating and rare missense variants in and and associations with cancer in UK Biobank whole-exome sequence data.和 中的蛋白截断和罕见错义变异与英国生物银行全外显子组序列数据中的癌症关联。
J Med Genet. 2024 Oct 23;61(11):1016-1022. doi: 10.1136/jmg-2024-110127.
8
Comprehensive analysis of the functional impact of single nucleotide variants of human CHEK2.全面分析人类 CHEK2 单核苷酸变异的功能影响。
PLoS Genet. 2024 Aug 15;20(8):e1011375. doi: 10.1371/journal.pgen.1011375. eCollection 2024 Aug.
9
Relationship between the Expression of CHK2 and p53 in Tumor Tissue and the Course of Papillary Thyroid Cancer in Patients with Germline Mutations.种系突变患者肿瘤组织中CHK2和p53表达与甲状腺乳头状癌病程的关系
Cancers (Basel). 2024 Feb 17;16(4):815. doi: 10.3390/cancers16040815.
10
Impaired end joining induces cardiac atrophy in a Hutchinson-Gilford progeria mouse model.末端连接受损导致哈钦森-吉尔福德早衰症小鼠模型的心脏萎缩。
Proc Natl Acad Sci U S A. 2023 Nov 21;120(47):e2309200120. doi: 10.1073/pnas.2309200120. Epub 2023 Nov 15.